AstraZeneca’s Japan Partner to Go Solo on Future Cancer Drugs
When Japanese pharmaceutical company Daiichi Sankyo Co. discovered a groundbreaking cancer treatment, it turned to bigger Western drugmaker AstraZeneca Plc. to help commercialize the therapy that has the potential to replace chemotherapy.








